Taylor Farms Colorado, Inc.

• Foodborne Biological Hazards

  Food/Cosmetics · FY 2014

  NAI

No citation rows are linked to this inspection in the current dataset. That absence does not prove FDA issued no observations or Form 483; citation coverage and published-483 coverage are separate.

1. 1

   Confirm identity, date, and inspected scope

   Verify InspectionID 890942, FEI 1783599, each project-area row, product type, location, and inspection end date against the FDA classification source. A classification applies to the closed inspected scope; it cannot be generalized to another site, product, project area, or current operating state.

2. 2

   Audit every Form 483 candidate

   Review all 1 same-FEI index candidate, preserving FEI/date matches, firm-only context, and date conflicts rather than selecting a convenient record. The public index may omit InspectionID. FEI alone identifies facility context but does not prove that a document belongs to this exact inspection.

3. 3

   Read the actual inspection documents

   Obtain and read the exact Form FDA 483 and EIR before summarizing observations; retain observation numbers, investigator examples, page locators, redactions, and document limitations. Citation rows and index metadata cannot reconstruct investigator observations, and a Form FDA 483 is not a final agency violation determination.

4. 4

   Map requirements to response and CAPA evidence

   Use the exact citation rows and current eCFR navigation, then compare the primary observations with the firm response, root-cause analysis, corrective actions, preventive actions, and effectiveness evidence. A provision label alone does not disclose the observed facts, severity, root cause, remediation quality, or present operating controls.

5. 5

   Research subsequent records independently

   Search later inspections, exact FDA Warning Letters, import alerts, recalls, and enforcement records, then obtain current facility evidence before making a material supplier decision. OAI does not identify a particular action, while any closed classification remains historical evidence rather than a current compliance or supplier verdict.

What does FDA report for inspection 890942?

Taylor Farms Colorado, Inc. inspection 890942 ended August 12, 2014. FDA posted NAI: No Action Indicated across 1 project-area row, and the local corpus joins 0 exact citation rows. This is the closed inspection record, not a current facility verdict.

What does NAI mean for inspection 890942?

Taylor Farms Colorado, Inc. inspection 890942 has NAI: No Action Indicated. FDA found no objectionable conditions or practices during the inspected project area. NAI is scoped to that inspection and does not certify the firm’s current or future compliance. If several project-area codes are posted, the headline is only a navigation summary; interpret every visible row within its inspected scope.

Which provisions are linked to inspection 890942?

Taylor Farms Colorado, Inc. inspection 890942 has no exact citation row in the current local citation corpus. That is a coverage gap, not evidence that investigators made no observations or issued no Form FDA 483. Obtain the primary inspection documents before treating the record as complete.

Is a Form FDA 483 linked to inspection 890942?

Taylor Farms Colorado, Inc. inspection 890942 has 0 high-confidence Form 483 index links, 0 firm-context candidates, and 1 date-conflicting candidate. None is called an exact InspectionID match because the admitted OII index rows do not expose that identifier.

What scope did inspection 890942 cover?

Taylor Farms Colorado, Inc. inspection 890942 covers Foodborne Biological Hazards for Food/Cosmetics at Colorado Springs, Colorado, United States. The page preserves every exact project-area row, classification, fiscal year, and additional detail; it does not generalize beyond that closed scope.

What other FDA inspections are linked to this facility?

Taylor Farms Colorado, Inc. inspection 890942 belongs to an exact-FEI history containing 6 distinct inspection IDs, including 1 earlier and 4 later records relative to the target. Counts are deduplicated by InspectionID and remain historical context, not a compliance score.

Do cited provisions recur across this facility’s inspections?

Taylor Farms Colorado, Inc. inspection 890942 is in a current facility history where no normalized provision appears across at least two distinct InspectionIDs. This bounded corpus result does not prove that no observation recurred because inspection, citation, and document coverage may be incomplete or unavailable.

Did FDA take action after inspection 890942?

Taylor Farms Colorado, Inc. inspection 890942 has no independently researched follow-up action in this generated profile. Warning Letters, import alerts, recalls, injunctions, seizures, and other actions remain explicitly unresearched; NAI alone cannot establish that any particular action occurred or describe the firm’s response.

Does inspection 890942 establish current compliance?

Taylor Farms Colorado, Inc. inspection 890942 does not establish the facility’s current compliance, supplier suitability, future performance, or remediation success. NAI describes FDA’s final classification of a closed inspection and its posted project-area scope. Current decisions require later official records plus current quality-system, CAPA, and operational evidence.

How complete is the record for inspection 890942?

Taylor Farms Colorado, Inc. inspection 890942 includes exact classification rows, 0 exact citation rows, and a complete same-FEI Form 483 candidate audit for the loaded corpus. It does not include reviewed Form 483 or EIR text or independently researched enforcement sources, and FDA says its inspection database is not comprehensive.

How should inspection 890942 be used in due diligence?

Use Taylor Farms Colorado, Inc. inspection 890942 to anchor identity, date, scope, classifications, exact citations, candidate documents, and facility history. Then read the primary inspection documents, map observations to requirements and CAPA evidence, research subsequent FDA actions separately, and obtain current evidence before making a supplier or compliance decision.